$Hims & Hers Health(HIMS.US)Missed the boat when it dropped below $15 earlier. The partnership with Nvo is a win win for both companies. However Nvo still faces a lot of price pressure from US government and competition from Eli lly. Hims need more than Nvo sales right to turn around company. Need more user base growth to boost income and earnings.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
